Skip to main content
Premium Trial:

Request an Annual Quote

BGI Opens Genomics Research Center in Copenhagen


BGI has opened a genomics research center in Copenhagen's Bio Science Park that will be equipped with 10 Illumina HiSeq 2000 sequencers.

The goal of the center is to establish collaborations in genomics research and its applications to health care, agriculture, and bioenergy.

The center will kick off with two main initiatives: a cancer vaccine project and the 1% Danes' Genome Project.

The cancer vaccine project aims to use sequencing to identify unknown cancer pathogens and develop and patent commercial vaccines.

The 1% Dane's Genome Project is a collaboration between BGI and the University of Copenhagen, Aarhus University, Aalborg University, Herlev Hospital, and the Technical University of Denmark. The effort will sequence the genomes of 50,000 Danish citizens in order to build a database for disease research.

The research center is part of BGI Europe's efforts, which was established in May 2010 in Copenhagen, but until now has been primarily a sales and marketing effort (IS 7/5/2011).

The Scan

Genetic Testing Approach Explores Origins of Blastocyst Aneuploidy

Investigators in AJHG distinguish between aneuploidy events related to meiotic missegregation in haploid cells and those involving post-zygotic mitotic errors and mosaicism.

Study Looks at Parent Uncertainties After Children's Severe Combined Immunodeficiency Diagnoses

A qualitative study in EJHG looks at personal, practical, scientific, and existential uncertainties in parents as their children go through SCID diagnoses, treatment, and post-treatment stages.

Antimicrobial Resistance Study Highlights Key Protein Domains

By screening diverse versions of an outer membrane porin protein in Vibrio cholerae, researchers in PLOS Genetics flagged protein domain regions influencing antimicrobial resistance.

Latent HIV Found in White Blood Cells of Individuals on Long-Term Treatments

Researchers in Nature Microbiology find HIV genetic material in monocyte white blood cells and in macrophages that differentiated from them in individuals on HIV-suppressive treatment.